GNTA (Genenta Science SPA) EBITDA Margin %: 0.00% (As of Dec. 2025)


GNTA Genenta Science SPA GNTA
31 GF Score
Price $1.53
! 4 Warning Signs
View Full Analysis

What is Genenta Science SPA EBITDA Margin %?

Genenta Science SPA GNTA -5.26% 31 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates GNTA with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 935 Biotechnology companies, Genenta Science SPA ranks worse than 106951.76% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Genenta Science SPA's EBITDA for the six months ended in Dec. 2025 was $-3.76 Mil. Genenta Science SPA's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Genenta Science SPA's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Genenta Science SPA  (NAS:GNTA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Genenta Science SPA EBITDA Margin % Related Terms

Genenta Science SPA EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Genenta Science SPA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genenta Science SPA EBITDA Margin % Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GNTA vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Genenta Science SPA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's EBITDA Margin % falls into.


GNTA
31GF Score
Genenta Science SPA GNTA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genenta Science SPA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Genenta Science SPA's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.7/0
= %

Genenta Science SPA's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.755/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Genenta Science SPA (GNTA) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genenta Science SPA and its competitors. According to the industry distribution chart, Genenta Science SPA ranks #999999 out of 935 companies in the Biotechnology industry.
Is Genenta Science SPA's EBITDA Margin % too high?
Genenta Science SPA's current EBITDA Margin % is 0.00%. Based on the distribution chart, Genenta Science SPA ranks #999999 out of 935 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Genenta Science SPA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genenta Science SPA ranks #999999 out of 935 companies for EBITDA Margin %. This places Genenta Science SPA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genenta Science SPA and its competitors. Genenta Science SPA's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (GNTA) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Genenta Science SPA's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Genenta Science SPA (GNTA), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genenta Science SPA Business Description

Other Exchanges K5F:Germany
Address Via dell’Annunciata No. 31, Milan, ITA, 20121
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
31GF Score

Get the complete analysis for GNTA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.53
Price